Immunomodulatory drugs

Show results for

Unknown (1367)
Genomics (143)
Transcriptomics (112)
Proteomics (55)
Metabolomics (9)
Other (5)
Methylation profiling (4)
Genomic (2)
Clinical (2)
Multiomics (1)

Organisms

Homo sapiens (107)
Mus musculus (45)
Andropogon gerardi (30)
Bacteria (30)
Borrelia (30)
Botrytis cinerea (30)
Candida albicans (30)
Canis lupus familiaris (30)
Clostridium perfringens (30)
Cnidaria (30)
Eukaryota (30)
Fasciola (30)
Fungi (30)
Hepatitis B virus (30)
Human betaherpesvirus 5 (30)
Influenza C virus (30)
Japanese encephalitis virus group (30)
Miscanthus x giganteus (30)
Mus musculus (30)
Mycobacterium tuberculosis (30)
Orthoflavivirus (30)
Rattus norvegicus (3)
Fusarium oxysporum (1)
Macaca fascicularis (1)
Streptococcus agalactiae (1)
Zea mays (1)
Aspergillus fumigatus Af293 (1)
Mycobacterium tuberculosis H37Rv (1)
feces metagenome (1)
Oryctolagus cuniculus (1)

Organisms

Homo sapiens (62)
Mus musculus (31)
Rattus norvegicus (3)
feces metagenome (1)

Repository

ENA (119)
geo (92)
biostudies-arrayexpress (48)
pride (30)
jPOST (12)
MetaboLights (9)
MassIVE (7)
EGA (5)
iProX (5)
dbGaP (2)
PanoramaPublic (1)

Tissue

Cell culture (19)
B cell (2)
Blood cell (2)
Epithelial cell (2)
Liver (2)
Blood (1)
Bone marrow (1)
Cell suspension culture (1)
Early embryonic cell (1)
Kidney (1)
Lymphoblast (1)
Monocyte (1)
Permanent cell line cell (1)

Disease

Multiple myeloma (3)
Intestinal Neoplasms (1)
Colorectal Neoplasms (1)
Chronic myelogenous leukemia (1)
Hepatocellular carcinoma (1)
Lymphoma (1)

Technology Type

Mass Spectrometry (30)
Data-independent acquisition (11)
Shotgun proteomics (7)
Affinity purification coupled with mass spectrometry proteomics (6)
Mass spectrometry (5)
Bottom-up proteomics (5)
Mass spectrometry assay (4)
Data-dependent acquisition (2)
Affinity proteomics (1)

Instrument Platform

Liquid Chromatography MS - positive - reverse phase (4)
Liquid Chromatography MS - negative - reverse phase (4)
Illumina NovaSeq 6000 (3)
NextSeq 500 (2)
Liquid Chromatography MS - negative - reverse-phase (2)
Liquid Chromatography MS - positive - reverse-phase (2)
Liquid Chromatography MS - positive - hilic (2)
Dr. Tom Multi-omics Data Mining System (1)
Animal Experiment Facility (1)
SPF Animal Room (1)
PCR Thermocycler, Fragment Analyzer (1)
Centrifuge, Nucleic Acid Quantification Instrument (1)
Biosafety Cabinet, Liquid Nitrogen Tank, -80°C Freezer (1)
Illumina NovaSeq X (1)
NextSeq 2000 (1)
DNBSEQ-T7 (1)
Illumina HiSeq 2000 (1)
LTQ (1)
Orbitrap Eclipse (1)
Orbitrap Exploris 480 (1)
Orbitrap Fusion (1)
Orbitrap Fusion Lumos (1)
Orbitrap Fusion Lumos (Thermo Scientific instrument model) (1)
Q Exactive (1)
Q Exactive HF (1)
Q Exactive Plus (1)
TimsTOF fleX (1)
Liquid Chromatography MS - alternating - reverse-phase (1)
Liquid Chromatography MS - negative - hilic (1)

Publication Date

2025 (32)
2023 (30)
2026 (24)
2024 (23)
2021 (21)
2011 (13)
2020 (8)
2014 (8)
2013 (7)
2022 (7)
2017 (6)
2015 (5)
2010 (5)
2012 (4)
2016 (3)
2019 (3)
2007 (2)
2009 (1)
2018 (1)

CHEBI ID

CHEBI:16264 (3)
CHEBI:16675 (3)
CHEBI:15682 (2)
CHEBI:89825 (2)
CHEBI:43355 (2)
CHEBI:16704 (2)
CHEBI:27897 (2)
CHEBI:15756 (2)
CHEBI:17858 (2)
CHEBI:16796 (2)
CHEBI:16467 (2)
CHEBI:18344 (2)
CHEBI:17596 (2)
CHEBI:24813 (2)
CHEBI:17368 (2)
CHEBI:17345 (2)
CHEBI:48153 (2)
CHEBI:16919 (2)
CHEBI:30769 (2)
CHEBI:32805 (2)
CHEBI:15843 (2)
CHEBI:29016 (2)
CHEBI:16708 (2)
CHEBI:17645 (2)
CHEBI:15793 (2)
CHEBI:28238 (2)
CHEBI:10072 (2)
CHEBI:15318 (2)
CHEBI:16765 (2)
CHEBI:15741 (2)

Metabolite Name

Isopentenyladenine (2)
EDTA (2)
D-Pinitol (2)
Prostaglandin E1 (2)
Dodecylbenzenesulfonic acid (2)
Phosphoenolpyruvic acid (2)
2,6-Dihydroxybenzoic acid (2)
Phthalic acid (2)
Acetylglycine (2)
Purine (2)
Serine (2)
Indole (2)
Octadecanedioic acid (2)
3-Aminosalicylic acid (2)
Sebacic acid (2)
UDP-N-acetyl-alpha-D-glucosamine (2)
2'-Deoxyuridine (2)
Indoxyl sulfate (2)
3-Hydroxybutyric acid (2)
Dodecanoic acid (2)
Dihydroxyacetone phosphate (2)
Pyruvate (2)
Methylmalonic acid (2)
Xanthine (2)
Canrenone (2)
Xanthosine (2)
Uric acid (2)
Trans-Aconitic acid (2)
Threonic acid (2)
Pentadecanoic acid (2)

First Public Date

2026 (21)
2024 (17)
2023 (17)
2025 (15)
2020 (10)
2014 (10)
2021 (9)
2022 (6)
2019 (6)
2017 (5)
2018 (1)
2016 (1)
2015 (1)

Modification

N6-dimethyl-L-lysine (1)

Study status

Not provided (1)
Completed (1)

Study type

Transcription profiling by array (33)
RNA-seq of coding RNA (5)
Methylation profiling by array (2)
RNA-seq of coding RNA from single cells (2)
Interventional (2)
Cell line - High-throughput sequencing (1)
Genotyping by array (1)
Transcription profiling by RT-PCR (1)
Comparative genomic hybridization by array (1)
ChIP-seq (1)
RNA-seq of total RNA (1)

Release Date

2022 (226)
2021 (212)
2023 (193)
2020 (172)
2025 (123)
2024 (95)
2019 (81)
2017 (57)
2018 (49)
2016 (48)
2015 (36)
2014 (31)
2011 (20)
2026 (18)
2013 (18)
2012 (15)
2010 (9)
2009 (5)
2008 (3)
2007 (2)
2004 (1)
2000 (1)

Lab affiliation

Dr. Matthias Gstaiger ETH Zürich Institute of Molecular Systems Biology Otto-Stern-Weg 3 8093 Zürich Switzerland (5)
ETH Zürich Institute of Molecular Systems Biology HPM F43 Otto-Stern-Weg 3 8093 Zürich Switzerland (5)
ETHZ IMSB (4)
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA (2)
AG Proteomics & Bioanalytics Institut für Experimentelle Medizin Christian-Albrechts-Universität zu Kiel 24105 Kiel, Germany (1)
Beijing Institute of Pharmacology and Toxicology (1)
Biomedical Research Novartis Pharma AG (1)
Cellular Proteome Research, Helmholtz-Centre for Infection Research, Braunschweig, Germany (1)
Chair of protomeics and bioanalytics, Technical University of Munich, Freising, Germany (1)
Department of Pathology, Brigham & Women's Hospital, Harvard Medical School, Boston, MA 02115, USA (1)
ETH Zurich Dr. Matthias Gstaiger Institute of Molecular Systems Biology HPM F43 Otto-Stern-Weg 3 8093 Zürich Switzerland (1)
Head of Haematology Research, School of Clinical Sciences, Monash University, Australia (1)
Institute of Biomedical Chemistry (1)
Institute of Molecular Systems Biology HPM F43 Otto-Stern-Weg 3 8093 Zürich Switzerland (1)
Molecular Proteomics Laboratory, Biological Medical Research Center, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany (1)
Novartis Institutes for Biomedical Research (1)
Professor Department of Laboratory Medicine and Pathology Mayo Clinic Rocheste Minnesota, USA (1)
Proteomics Platform, Max Delbrück Center for Molecular Medicine Berlin (1)

Location

New Zealand (1)
Egypt (1)

Keyword

Statin (1)
Atorvastatin (1)
ERAS (1)
Simvastatin (1)
Colorectal (1)
Colon (1)

Previous page
1 / 170
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 170
Next page

Sort by:

Relevance

Page size

ERK signaling mediates resistance to immunomodulatory drugs in the bone marrow microenvironment (CRISPR Screen)

PRJNA719239 | ENA

ERK signaling mediates resistance to immunomodulatory drugs in the bone marrow microenvironment (RNA-Seq)

PRJNA719234 | ENA

Genome-wide circular RNA expression patterns reflect resistance to immunomodulatory drugs in multiple myeloma cells

PRJNA680045 | ENA

Immunomodulatory Drugs in Melanoma Brain Metastases.

Not available

S-EPMC7086063 | biostudies-literature

Antitumor Potential of Immunomodulatory Natural Products.

Not available

S-EPMC9229642 | biostudies-literature

ERK signaling mediates resistance to immunomodulatory drugs in the bone marrow microenvironment

PRJNA719150 | ENA

Novel immunomodulatory drugs and neo-substrates.

Not available

S-EPMC6953231 | biostudies-literature

Immunomodulatory Drugs in the Management of SARS-CoV-2.

Not available

S-EPMC7438578 | biostudies-literature

Immune regulation by low doses of the DNA methyltransferase inhibitor 5-azacitidine in common human epithelial cancers [methylation]

Epigenetic therapy is emerging as a potential therapy for solid tumors. To investigate its mechanism of action, we performed integrative expression and methylation analysis of 63 cancer cell lines (breast, colorectal, and ovarian) after treatment with the DNA methyltransferase inhibitor 5-azacitidin...

ORGANISM(S): Homo sapiens

2014-05-08 | E-GEOD-57342 | biostudies-arrayexpress

Immunomodulatory Drugs in Acute Myeloid Leukemia Treatment.

Not available

S-EPMC7573974 | biostudies-literature

Previous page
1 / 170
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 170
Next page

Sort by:

Relevance

Page size

1699 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

CHEBI ID

Metabolite Name

First Public Date

Modification

Study status

Study type

Release Date

Lab affiliation

Location

Tags

Keyword

OmicsDI is part of the ELIXIR infrastructure

Tweets